12,025 Shares in Masimo Corporation $MASI Bought by Quantitative Investment Management LLC

Quantitative Investment Management LLC purchased a new stake in shares of Masimo Corporation (NASDAQ:MASI) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 12,025 shares of the medical equipment provider’s stock, valued at approximately $1,774,000.

Other institutional investors have also added to or reduced their stakes in the company. MAI Capital Management increased its position in shares of Masimo by 176.7% in the second quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 129 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of Masimo by 80.0% during the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 136 shares during the period. Allworth Financial LP boosted its holdings in shares of Masimo by 72.8% during the second quarter. Allworth Financial LP now owns 387 shares of the medical equipment provider’s stock worth $65,000 after purchasing an additional 163 shares during the period. Clearstead Advisors LLC grew its stake in shares of Masimo by 18.4% in the third quarter. Clearstead Advisors LLC now owns 470 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 73 shares during the last quarter. Finally, Hantz Financial Services Inc. grew its stake in shares of Masimo by 792.3% in the third quarter. Hantz Financial Services Inc. now owns 580 shares of the medical equipment provider’s stock worth $86,000 after purchasing an additional 515 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on MASI. Wells Fargo & Company lowered Masimo from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $190.00 to $180.00 in a research report on Wednesday, February 18th. Piper Sandler lowered Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective on the stock. in a research report on Tuesday, February 17th. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a report on Thursday, January 22nd. Needham & Company LLC reaffirmed a “hold” rating on shares of Masimo in a research note on Monday, December 1st. Finally, BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. One equities research analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Masimo has an average rating of “Hold” and an average target price of $181.17.

Masimo Stock Up 0.0%

Shares of NASDAQ:MASI opened at $175.50 on Friday. The firm has a market capitalization of $9.43 billion, a P/E ratio of -16.65, a P/E/G ratio of 1.78 and a beta of 1.21. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49. The stock has a 50 day moving average price of $150.84 and a 200-day moving average price of $145.65. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $175.90.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.